Alnylam Pharmaceuticals (ALNY)
114.70
-0.93 -0.80%
NASDAQ
Oct 20, 20:00
Delayed 2m
USD
View All Key Stats
ALNY Key Stats
| Income Statement | |
| Revenue (TTM) | 66.00M |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -5.11 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -442.72M |
| Profitability | |
| Gross Profit Margin (Quarterly) | -- |
| Profit Margin (Quarterly) | -743.3% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | 0.00 |
| Price and Valuation | |
| Market Cap | 10.52B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 150.20 |
| PE Ratio (TTM) | -- |
| Price to Book Value | 9.370 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | 0.1336 |
| Free Cash Flow (Quarterly) | -102.70M |
| Return on Equity (TTM) | -44.38% |
View All ALNY News
ALNY News
-
WireHeadlineTime (ET)
-
Business Wire10/20 07:00
-
Yahoo10/18 11:35
-
Yahoo10/18 11:09
-
Yahoo10/18 11:07
-
SA Breaking News10/18 09:13
-
MT Newswires10/18 08:09
-
Yahoo10/18 07:15
-
Business Wire10/18 07:01
-
Yahoo10/17 08:06
-
Yahoo10/13 08:07
View All Events
ALNY Events
| Date | Type | Description |
|---|---|---|
| 08/09/2018 | Misc | Alnylam Pharmaceuticals Inc Second Quarter Earnings Conference Call in 2018 |
| 08/09/2018 | Earnings | Alnylam Pharmaceuticals Inc Second Quarter Earnings Results in 2018 |
| 05/04/2018 | Misc | Alnylam Pharmaceuticals Inc First Quarter Earnings Conference Call in 2018 |
| 05/04/2018 | Earnings | Alnylam Pharmaceuticals Inc First Quarter Earnings Results in 2018 |
| 05/02/2018 | Misc | Alnylam Pharmaceuticals Inc Annual General Meeting in 2017 |
| 02/15/2018 | Misc | Alnylam Pharmaceuticals Inc Annual Report in 2017 |
| 02/08/2018 | Misc | Alnylam Pharmaceuticals Inc Fourth Quarter Earnings Conference Call in 2017 |
| 02/08/2018 | Earnings | Alnylam Pharmaceuticals Inc Fourth Quarter Earnings Results in 2017 |
| 11/02/2017 | Misc | Alnylam Pharmaceuticals Inc Third Quarter Earnings Conference Call in 2017 |
| 11/02/2017 | Earnings | Alnylam Pharmaceuticals Inc Third Quarter Earnings Results in 2017 |
ALNY Fundamentals
Income Statement View Statement
ALNY Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
ALNY One Page Reports
- One Page Report Download
ALNY Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Target Price | |
| Price | 114.70 |
| Price Target | Upgrade |
Edit
Profile
- URL: http://www.alnylam.com
- Investor Relations URL: http://investors.alnylam.com/index.cfm
- HQ State/Province: Massachusetts
- Sector: Healthcare
- Industry: Biotechnology
- Equity Style: Mid Cap/Growth
- Next Earnings Release: Nov. 02, 2017
- Last Earnings Release: Aug. 09, 2017
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: Alnylam Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in developing novel therapeutics based on RNA interference, or RNAi. RNAi is a naturally occurring biological pathway within cells for regulating the expression of specific genes.
ALNY Comparables
EditALNY Excel Add-In Codes
- Name: =YCI("ALNY","name")
- Description: =YCI("ALNY","description")
- Sector: =YCI("ALNY","sector")
- Industry: =YCI("ALNY","industry")
- Est. Current Fiscal Year End: =YCI("ALNY","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other ALNY Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- ALNY Tweets Stocktwits
Advertisement
